Pain Pharmacology Research Scientist: Ion Channel Focus

Pain Research Forum; San Diego (CA); Hybrid; USD 111,000 - 166,000; Full time

Benefits offered by this job

Annual bonus

Equity awards

Comprehensive benefits

Paid time off

401(k) matching

Job summary

Vertex Pharmaceuticals is seeking a Pharmacology Research Scientist to join our pain pharmacology group in San Diego. This lab-based role involves designing mechanistic studies, developing cellular models of neuronal function, and analyzing data to guide decision-making.

The successful candidate will utilize electrophysiological and imaging techniques, including human cells, and collaborate with a multidisciplinary drug discovery team to advance pain-targeted therapies.

Qualifications

• PhD and 0-3 years of experience or
• Masters degree and 3 years of experience or
• Bachelors degree and 6 years of experience

Responsibilities

• Design and execute pharmacology studies focused on ion channel modulation.
• Develop cellular models to study neuronal excitation, action potential propagation, and neurotransmitter release.
• Analyze, interpret and communicate pharmacological data to project teams.
• Collaborate with technology teams to integrate advanced tools into workflows.
• Ensure high standards of scientific documentation and communication.

Skills

Ion channel pharmacology

Electrophysiology

Imaging techniques

Neuronal signaling assays

Primary human cells

Scientific communication

Team collaboration

Education

PhD

Masters

Bachelors

Tools

Electrophysiology equipment

Imaging systems

Job description

Vertex Pharmaceuticals is seeking a Pharmacology Research Scientist to join our pain pharmacology group in San Diego. This lab-based role involves designing mechanistic studies, developing cellular models of neuronal function, and analyzing data to guide decision-making.

The successful candidate will utilize electrophysiological and imaging techniques, including human cells, and collaborate with a multidisciplinary drug discovery team to advance pain-targeted therapies.